Patents by Inventor Philipp Wagner

Philipp Wagner has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10722538
    Abstract: The present invention relates to peptides, proteins, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates to the immunotherapy of cancer. The present invention furthermore relates to tumor-associated T-cell peptide epitopes, alone or in combination with other tumor-associated peptides that can for example serve as active pharmaceutical ingredients of vaccine compositions that stimulate anti-tumor immune responses, or to stimulate T cells ex vivo and transfer into patients. Peptides bound to molecules of the major histocompatibility complex (MHC), or peptides as such, can also be targets of antibodies, soluble T-cell receptors, and other binding molecules.
    Type: Grant
    Filed: January 31, 2020
    Date of Patent: July 28, 2020
    Assignee: IMMATICS BIOTECHNOLOGIES GMBH
    Inventors: Heiko Schuster, Janet Peper, Philipp Wagner, Hans-Georg Rammensee
  • Publication number: 20200229549
    Abstract: A holding device (10) for holding a component (12), the holding device (10) being convertible from a component holding mode into a component release mode by magnetic force. The holding device (10) for holding the component (12) has a movable detent element (14), the position of which is not influenced by the magnetic force. A method for releasing a snap-in connection between a holding device (10) and a component (12) is also provided, having the following steps: generating a magnetic field in the vicinity of the holding device (10); and applying a force that moves the holding device (10) and the component (12) apart from each other to release the snap-in connection.
    Type: Application
    Filed: January 17, 2020
    Publication date: July 23, 2020
    Applicant: SFS intec Holding AG
    Inventors: Kai HEINEKE, Marlon WAGNER, Philipp GENTNER
  • Publication number: 20200155603
    Abstract: The present invention relates to peptides, proteins, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates to the immunotherapy of cancer. The present invention furthermore relates to tumor-associated T-cell peptide epitopes, alone or in combination with other tumor-associated peptides that can for example serve as active pharmaceutical ingredients of vaccine compositions that stimulate anti-tumor immune responses, or to stimulate T cells ex vivo and transfer into patients. Peptides bound to molecules of the major histocompatibility complex (MHC), or peptides as such, can also be targets of antibodies, soluble T-cell receptors, and other binding molecules.
    Type: Application
    Filed: January 31, 2020
    Publication date: May 21, 2020
    Inventors: Heiko SCHUSTER, Janet PEPER, Philipp WAGNER, Hans-Georg RAMMENSEE
  • Patent number: 10639331
    Abstract: The present invention relates to peptides, proteins, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates to the immunotherapy of cancer. The present invention furthermore relates to tumor-associated T-cell peptide epitopes, alone or in combination with other tumor-associated peptides that can for example serve as active pharmaceutical ingredients of vaccine compositions that stimulate anti-tumor immune responses, or to stimulate T cells ex vivo and transfer into patients. Peptides bound to molecules of the major histocompatibility complex (MHC), or peptides as such, can also be targets of antibodies, soluble T-cell receptors, and other binding molecules.
    Type: Grant
    Filed: August 30, 2019
    Date of Patent: May 5, 2020
    Assignee: IMMATICS BIOTECHNOLOGIES GMBH
    Inventors: Heiko Schuster, Janet Peper, Philipp Wagner, Hans-Georg Rammensee
  • Patent number: 10639332
    Abstract: The present invention relates to peptides, proteins, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates to the immunotherapy of cancer. The present invention furthermore relates to tumor-associated T-cell peptide epitopes, alone or in combination with other tumor-associated peptides that can for example serve as active pharmaceutical ingredients of vaccine compositions that stimulate anti-tumor immune responses, or to stimulate T cells ex vivo and transfer into patients. Peptides bound to molecules of the major histocompatibility complex (MHC), or peptides as such, can also be targets of antibodies, soluble T-cell receptors, and other binding molecules.
    Type: Grant
    Filed: August 30, 2019
    Date of Patent: May 5, 2020
    Assignee: IMMATICS BIOTECHNOLOGIES GMBH
    Inventors: Heiko Schuster, Janet Peper, Philipp Wagner, Hans-Georg Rammensee
  • Publication number: 20200124029
    Abstract: Disclosed are wind farms with wind generators in several levels on top of each other. The wind generators are mounted on top of each other on towers. The towers are guyed using tendons. The tendons run crosswise between the towers. Additional safety tendons provide the wind farm against structural failure. A procedure for controlling the wind generators improves the yield. The method for controlling the wind generators also reduces load peaks and the propagation of vibrations within the interconnected support structure. Various other damping methods are also used.
    Type: Application
    Filed: June 25, 2018
    Publication date: April 23, 2020
    Inventor: Philipp WAGNER
  • Publication number: 20200104378
    Abstract: Systems and methods are described for providing an implementation of the MapReduce programming model utilizing tasks executing on an on-demand code execution system, utilizing a stream data processing system as an intermediary between map and reduce function. A map task implementing a map function can process portions of a data set, to generate outputs associated with different values for a measured attribute of the data set. Executions of the map task can publish outputs to a data stream on the stream data processing system, which stream is configured to utilize the measured attribute as a partition key for the stream. Based on the partition key, the stream data processing system can divide the stream into sub-streams, each containing a relevant subset of the outputs. The on-demand code execution system can execute a reduce task to apply the reduce function to the outputs of each sub-stream, thereby completing the MapReduce process.
    Type: Application
    Filed: September 27, 2018
    Publication date: April 2, 2020
    Inventors: Timothy Allen Wagner, Hans-Philipp Anton Hussels, Marc John Brooker
  • Publication number: 20200104198
    Abstract: Systems and methods are described for providing maintaining state information during processing of data sets via execution of code on an on-demand code execution system. Rather than requiring that execution environments of such a system to maintain state, an intermediary device is disclosed which retrieves calls to the system from a call queue and iteratively submits the calls to the system. Each call within the queue corresponds to a data item of the data set to be analyzed. As calls are submitted to the system, the intermediary device submits state information within the call reflecting a state of processing the data set. A response to the call includes state information updated based on processing of a data item in the call. Thus, state information is maintained for processing the data set, without requiring persistence of state information within individual execution environments.
    Type: Application
    Filed: September 27, 2018
    Publication date: April 2, 2020
    Inventors: Hans-Philipp Anton Hussels, Timothy Allen Wagner, Marc John Brooker
  • Patent number: 10568909
    Abstract: The present invention relates to peptides, proteins, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates to the immunotherapy of cancer. The present invention furthermore relates to tumor-associated T-cell peptide epitopes, alone or in combination with other tumor-associated peptides that can for example serve as active pharmaceutical ingredients of vaccine compositions that stimulate anti-tumor immune responses, or to stimulate T cells ex vivo and transfer into patients. Peptides bound to molecules of the major histocompatibility complex (MHC), or peptides as such, can also be targets of antibodies, soluble T-cell receptors, and other binding molecules.
    Type: Grant
    Filed: August 30, 2019
    Date of Patent: February 25, 2020
    Assignee: Immatics Biotechnologies GmbH
    Inventors: Heiko Schuster, Janet Peper, Philipp Wagner, Hans-Georg Rammensee
  • Publication number: 20200000849
    Abstract: The present invention relates to peptides, proteins, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates to the immunotherapy of cancer. The present invention furthermore relates to tumor-associated T-cell peptide epitopes, alone or in combination with other tumor-associated peptides that can for example serve as active pharmaceutical ingredients of vaccine compositions that stimulate anti-tumor immune responses, or to stimulate T cells ex vivo and transfer into patients. Peptides bound to molecules of the major histocompatibility complex (MHC), or peptides as such, can also be targets of antibodies, soluble T-cell receptors, and other binding molecules.
    Type: Application
    Filed: August 30, 2019
    Publication date: January 2, 2020
    Inventors: Heiko SCHUSTER, Janet PEPER, Philipp WAGNER, Hans-Georg RAMMENSEE
  • Publication number: 20200000850
    Abstract: The present invention relates to peptides, proteins, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates to the immunotherapy of cancer. The present invention furthermore relates to tumor-associated T-cell peptide epitopes, alone or in combination with other tumor-associated peptides that can for example serve as active pharmaceutical ingredients of vaccine compositions that stimulate anti-tumor immune responses, or to stimulate T cells ex vivo and transfer into patients. Peptides bound to molecules of the major histocompatibility complex (MHC), or peptides as such, can also be targets of antibodies, soluble T-cell receptors, and other binding molecules.
    Type: Application
    Filed: August 30, 2019
    Publication date: January 2, 2020
    Inventors: Heiko SCHUSTER, Janet PEPER, Philipp WAGNER, Hans-Georg RAMMENSEE
  • Publication number: 20190387660
    Abstract: In various exemplary embodiments, a seed mat for insertion into an apparatus for growing plants is provided, wherein the seed mat includes a carrier substrate and seeds, wherein the seeds are fixed on the carrier substrate by means of an adhesive. Furthermore, a method for producing a seed mat in various exemplary embodiments may include: applying an adhesive on a carrier substrate; applying seeds on the carrier substrate provided with the adhesive; and fixing the seeds by the adhesive on the carrier substrate.
    Type: Application
    Filed: June 20, 2019
    Publication date: December 26, 2019
    Inventors: Maximilian Loessl, Philipp Wagner
  • Publication number: 20190381103
    Abstract: The present invention relates to peptides, proteins, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates to the immunotherapy of cancer. The present invention furthermore relates to tumor-associated T-cell peptide epitopes, alone or in combination with other tumor-associated peptides that can for example serve as active pharmaceutical ingredients of vaccine compositions that stimulate anti-tumor immune responses, or to stimulate T cells ex vivo and transfer into patients. Peptides bound to molecules of the major histocompatibility complex (MHC), or peptides as such, can also be targets of antibodies, soluble T-cell receptors, and other binding molecules.
    Type: Application
    Filed: August 30, 2019
    Publication date: December 19, 2019
    Inventors: Heiko SCHUSTER, Janet PEPER, Philipp WAGNER, Hans-Georg RAMMENSEE
  • Patent number: 10463696
    Abstract: The present invention relates to peptides, proteins, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates to the immunotherapy of cancer. The present invention furthermore relates to tumor-associated T-cell peptide epitopes, alone or in combination with other tumor-associated peptides that can for example serve as active pharmaceutical ingredients of vaccine compositions that stimulate anti-tumor immune responses, or to stimulate T cells ex vivo and transfer into patients. Peptides bound to molecules of the major histocompatibility complex (MHC), or peptides as such, can also be targets of antibodies, soluble T-cell receptors, and other binding molecules.
    Type: Grant
    Filed: November 15, 2017
    Date of Patent: November 5, 2019
    Assignee: IMMATICS BIOTECHNOLOGIES GMBH
    Inventors: Heiko Schuster, Janet Peper, Philipp Wagner, Hans-Georg Rammensee
  • Patent number: 10442475
    Abstract: A method for performing open-loop or closed-loop control of a driver's cab mount of a motor vehicle, wherein the driver's cab mount has dampers whose damper force can be adjusted, wherein the motor vehicle can be operated in a first driving mode in which the motor vehicle automatically carries out vehicle guidance comprising both a longitudinal guidance operation and a transverse guidance operation of the motor vehicle, and in a second driving mode where the motor vehicle can be controlled by the driver, in which driving mode a driver of the motor vehicle is intended to carry out at least part of the vehicle guidance, wherein when the motor vehicle is operated in the first driving mode, the adjustable dampers of the driver's cab mount are actuated or adjusted in such a way that pitching or rolling movements are reduced compared to the second driving mode.
    Type: Grant
    Filed: July 20, 2017
    Date of Patent: October 15, 2019
    Assignee: MAN TRUCK & BUS AG
    Inventors: Philipp Wagner, Jan Fleischhacker, Christian Kohrs
  • Publication number: 20190223391
    Abstract: In various embodiments, an apparatus for growing plants is provided. The apparatus may include an irrigation apparatus, an illumination apparatus, a climate control device, an accommodating space for accommodating one or more seed mats, a controller which is configured to control the irrigation apparatus, the illumination apparatus and the climate control apparatus by means of a program controller, at least one air humidity sensor for determining an air humidity in the accommodating space, and at least one temperature sensor for determining an air temperature in the accommodating space.
    Type: Application
    Filed: January 25, 2019
    Publication date: July 25, 2019
    Inventors: Maximilian Loessl, Philipp Wagner
  • Publication number: 20190223396
    Abstract: In various embodiments, an apparatus for growing plants is provided. The apparatus may include an irrigation apparatus, an accommodating space for accommodating one or more seed mats, and a controller which is configured to control the irrigation apparatus by a program controller. The irrigation apparatus includes a water circuit system for feeding water to the seed mats. The water circuit system includes at least one inlet, a water tank, at least one water circuit pump and at least one outlet. The irrigation apparatus includes a sensor which is configured to determine a conductance of the fed water.
    Type: Application
    Filed: January 24, 2019
    Publication date: July 25, 2019
    Inventors: Maximilian Loessl, Philipp Wagner
  • Publication number: 20180317400
    Abstract: A device for cultivating plants is provided, comprising a watering device, an illuminating device, one or more seed mats, and a control unit configured to control the watering device and the illuminating device by means of a program controller, wherein the program controller comprises watering data and illuminating data which is individually matched to the one or more seed mats.
    Type: Application
    Filed: October 21, 2016
    Publication date: November 8, 2018
    Inventors: Maximilian Lossl, Philipp Wagner
  • Publication number: 20180222961
    Abstract: The present invention relates to peptides, proteins, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates to the immunotherapy of cancer. The present invention furthermore relates to tumor-associated T-cell peptide epitopes, alone or in combination with other tumor-associated peptides that can for example serve as active pharmaceutical ingredients of vaccine compositions that stimulate anti-tumor immune responses, or to stimulate T cells ex vivo and transfer into patients. Peptides bound to molecules of the major histocompatibility complex (MHC), or peptides as such, can also be targets of antibodies, soluble T-cell receptors, and other binding molecules.
    Type: Application
    Filed: January 26, 2018
    Publication date: August 9, 2018
    Inventors: Heiko Schuster, Janet Peper, Kevin Röhle, Philipp Wagner, Hans-Georg Rammensee
  • Patent number: D893723
    Type: Grant
    Filed: February 15, 2018
    Date of Patent: August 18, 2020
    Assignee: OTTO BOCK HEALTHCARE PRODUCTS GMBH
    Inventors: Johannes Bischof, Alice Frey, Sandra Niederstrasser, Walter Lunzer, Markus Piller, Philipp Kampas, Sonja Wagner